Cases 1 - 10 of 1,697
Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.
as 24-1829
Plaintiff:
ALEXION PHARMACEUTICALS, INC. and ALEXION PHARMA INTERNATIONAL OPERATIONS LTD.
Defendant:
SAMSUNG BIOEPIS CO. LTD.
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2024cv00053
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 1:2024cv00577
Plaintiff:
Apotex Inc.
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al
as 1:2024cv00571
Plaintiff:
Breckenridge Pharmaceutical, Inc.
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit - III, Hetero Labs Limited. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Counter Claimant:
Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Progenics Pharmaceuticals, Inc. et al v. MIM Software Inc.
as 1:2024cv10437
Plaintiff:
Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB
Defendant:
MIM Software Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1402
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Eagle Pharmaceuticals, Inc. v. Apotex Inc. et al
as 1:2024cv00064
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
